Table 2.
Baseline cardiac screening procedures and subsequent MACE in renal transplant candidates stratified according to their risk status.
| Variable | Total (n = 267) | Low risk (n = 71) | High risk (n = 196) | P value∗ |
|---|---|---|---|---|
| Echocardiography (%) | ||||
| LV-hypertrophy | 181 (81.9) | 49 (77.8) | 132 (83.5) | 0.315 |
| LV ejection fraction (%) | 59.2 ± 5.7 | 60.2 ± 4 | 58.8 ± 6.3 | 0.171 |
| Septum diameter (mm) | 13.72 ± 2.1 | 13.5 ± 2.2 | 13.8 ± 2 | 0.205 |
| Noninvasive stress test (%) | 204 (76.4) | 56 (78.8) | 148 (75.5) | 0.567 |
| Conclusive Test (%) | 154 (57.7) | 37 (52.1) | 117 (59.7) | 0.054 |
| Stress Echocardiography (%) | 122 (45.7) | 27 (38) | 95 (48.5) | 0.130 |
| Conclusive Test (%) | 111 (41.6) | 24 (33.8) | 87 (44.4) | 0.667 |
| Treadmill ergometry (%) | 115 (43.1) | 37 (52.1) | 78 (39,8) | 0.073 |
| Conclusive Test (%) | 51 (19.1) | 14 (19.7) | 37 (18.9) | 0.333 |
| Stress test positive (%) | 28 (13.7) | 3 (5.4) | 25 (16.9) | 0.033 |
| Coronary angiography (%) | 58 (21.7) | 3 (4.2) | 55 (28.1) | <0.001 |
| Sign. coronary stenosis (%) | 38 (65.5) | 0 (0) | 38 (69.1) | 0.014 |
| Revascularization (%) | 18 (31) | 0 (0) | 18 (32.7) | 0.233 |
| Stress test and/or coronary angiography (%) | 220 (82.4) | 57 (80.3) | 163 (83.2) | 0.585 |
| Conclusive stress test and/or coronary angiography (%) | 176 (65.9) | 38 (53.5) | 138 (70.4) | 0.010 |
| Cardiovascular Event (%) | 41 (15.5) | 2 (2.8) | 39 (19.9) | 0.001 |
*P values for comparison between low-risk and high-risk patients.
CAD: coronary artery disease; CVD: cerebrovascular disease; HD: hemodialysis; PD: peritoneal dialysis; PVD: peripheral vascular disease; CA: coronary angiography; noninvasive stress test: stress echocardiography and/or treadmill ergometry.